XML 127 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Unaudited Condensed Interim Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets      
Cash and cash equivalents $ 3,666,389 $ 1,404,160 $ 2,083,696
Restricted cash 107,010 90,413
Prepaid expenses and other current assets 740,933 366,316 249,045
Total current assets 4,514,332 1,918,439 2,332,741
Other assets 80,000  
Equipment, net 1,011 1,721 3,824
Intangible assets, net 432,729 532,010 614,386
Total assets 5,028,072 2,452,170 2,950,951
Current liabilities      
Accounts payable and accrued liabilities 1,743,596 1,394,117 2,845,381
Deferred income 50,777 10,413
Total current liabilities 3,005,836 2,615,993 4,056,844
Convertible debentures, net 1,002,874  
Conversion feature liability 1,415,265  
Warrant liabilities 2,449,478 4,455,747 205,989
Other long-term liabilities 74,250 84,125 8,295
Total liabilities 7,947,703 7,155,865 4,271,128
Stockholders’ deficiency      
Common stock, value 49,149,464 39,760,287 27,956,155
Additional paid-in capital 18,661,446 17,288,430 15,589,229
Accumulated other comprehensive loss (104,301) (104,301) (84,728)
Accumulated deficit (70,626,302) (61,648,173) (47,884,515)
Total stockholders’ deficiency (2,919,631) (4,703,695) (1,320,177)
Total liabilities and stockholders’ deficiency 5,028,072 2,452,170 2,950,951
Related Party      
Current assets      
Related party note receivable, net 57,550
Current liabilities      
Current portion of promissory note – related party 1,211,463 1,211,463 1,211,463
Class B Preferred Shares      
Stockholders’ deficiency      
Preferred stock, value $ 62 62 62
Class A Restricted Common Shares      
Stockholders’ deficiency      
Class A restricted common shares, no par value, unlimited shares authorized, nil and 280,000 shares issued and outstanding as of December 31, 2023, and December 31, 2022   $ 3,103,620